Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer

NCT01242449 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Trastuzumab
DRUG: Vinorelbine

Sponsor

Vejle Hospital